Author: Andrew Rogers

Andrew Rogers is a freelance journalist based in Chicago, USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He graduated with a degree in Journalism from the University of Florida. Over the years, he has contributed to leading outlets such as The New York Times, CNN, and Reuters. Recognized for his sharp reporting and thoughtful analysis, Andrew delivers accurate and timely news that keeps readers updated on key national and global developments.

The weight-loss drug semaglutide—best known as the active ingredient in Wegovy—reduces the risk of heart attack and stroke regardless of how much weight a person loses, according to a major global study published in The Lancet. Researchers from University College London (UCL) analysed data from 17,604 adults aged 45 and over across 41 countries who were either overweight or obese. Half received weekly semaglutide injections, while the others were given a placebo. The study found that semaglutide cut the risk of major cardiovascular events by 20%, even for participants who lost little or no weight. The results suggest that the…

Read More

People taking antidepressants can experience significant differences in physical side-effects depending on the medication, according to new UK research. The study found that some antidepressants can lead to up to 2kg of weight gain within two months, while others can cause comparable weight loss. The analysis, conducted by King’s College London and the University of Oxford, examined data from 151 clinical studies involving more than 58,000 participants and 30 different antidepressants. It revealed notable variations in weight change, heart rate, and blood pressure across different drugs. For instance, average weight changes ranged from a 2.5kg loss with agomelatine to a…

Read More

Pizza Hut’s UK restaurant operator has entered administration, leading to the closure of 68 dine-in locations and 11 delivery-only sites, putting 1,210 jobs at risk. Franchise holder DC London Pie appointed corporate finance firm FTI Consulting as administrators on Monday. However, a pre-pack deal with US parent company Yum! Brands — which also owns KFC and Taco Bell — will save 64 restaurants and 1,276 jobs, with those sites now to be operated directly by Yum. The closures affect branches nationwide, from Finchley Lido in London to Carlisle and Rhyl in north Wales. FTI’s Matt Callaghan said the sale “provides…

Read More

President Donald Trump has signed an $8.5 billion rare earths deal with Australia to secure essential minerals and strengthen U.S. supply chains. The agreement aims to reduce reliance on Chinese exports and support domestic industries. The deal was finalized after months of negotiations between the two governments. Officials emphasized that it is a strategic move to secure materials critical for technology, defense, and renewable energy sectors. Rare earths are used in electric vehicles, wind turbines, smartphones, and advanced military equipment. “This deal is about America’s security and economic strength,” Trump said. “We are ensuring our industries have the materials they…

Read More

Millions of young people could miss out on effective treatments because so few take part in medical research, experts warn. Data shows 18- to 24-year-olds make up 8% of England’s population but only 4.4% of clinical trial participants, raising concerns that future treatments may not suit their needs. “Young people face unique health challenges, from mental health issues to chronic conditions like asthma and diabetes,” said Kirsty Blenkins of the Association for Young People’s Health. “If research excludes them, treatments may be unsafe or ineffective.” Barriers include low awareness, limited recruitment, and privacy concerns. Dr Esther Mukuka of the NIHR…

Read More

A new “smart jab” has shown remarkable results in shrinking head and neck cancer tumours within just six weeks, offering fresh hope for patients with few treatment options left. The drug, amivantamab, works through a triple-action mechanism and can be administered as a simple injection rather than lengthy hospital infusions. It was tested in the Orig-AMI 4 trial, involving patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) across 11 countries, including the UK. Results presented at the European Society for Medical Oncology conference in Berlin showed that 76% of patients who had already undergone chemotherapy and…

Read More

Paramount Skydance is set to lay off about 2,000 employees in the US starting the week of 27 October as part of a $2 billion cost-cutting plan under new CEO David Ellison, according to Variety. The cuts come just two months after Skydance Media completed its $8.4 billion merger with Paramount Global in August. Additional international layoffs are expected, with full details likely to be announced in the company’s third-quarter earnings report on 10 November. Variety previously reported that Paramount planned to eliminate between 2,000 and 3,000 jobs by early November. As of December 2024, Paramount employed roughly 18,600 full-…

Read More

Artificial intelligence (AI) innovation is playing a key role in helping the United States reach its net zero goals, according to a recent study. Researchers highlight that AI, alongside clean energy adoption and digital economy growth, is essential for reducing CO₂ emissions and promoting environmental sustainability. The study shows that AI-driven technologies can optimize energy use, improve efficiency in industrial processes, and support smarter energy grids. These advancements allow businesses and governments to cut emissions while maintaining productivity and economic growth. Clean energy adoption, including solar, wind, and other renewable sources, works hand-in-hand with AI innovation. AI tools can predict…

Read More

A long-acting injection to prevent HIV is set to be approved for use in England and Wales, offering an alternative to daily oral medication. The treatment, known as cabotegravir (CAB-LA), is administered every two months and provides a new option for people unable to take traditional daily PrEP (pre-exposure prophylaxis) pills. PrEP is used by HIV-negative individuals to reduce the risk of infection. In new draft guidance, the National Institute for Health and Care Excellence (Nice) recommended the injection for adults and young people at higher risk of HIV who cannot use oral PrEP. The jab is already available on…

Read More

Nestlé will eliminate 16,000 jobs worldwide — nearly 6% of its workforce — over the next two years as part of a major cost-cutting plan to boost sales and efficiency. The layoffs include 12,000 white-collar roles and 4,000 in manufacturing and supply chains. “The world is changing and Nestlé needs to change faster,” said new CEO Philipp Navratil, who took over last month after the dismissal of Laurent Freixe. Navratil is accelerating cost-saving targets to 3 billion Swiss francs (£2.8bn) by 2027 and aims to foster a “performance-driven culture.” The maker of KitKat and Nescafé employs about 4,200 people in…

Read More